We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

CHRONIC INVESTOR BLOG

Our light-hearted take on the world of investing

Today

Chart: A FTSE 100 post-admission bounce?

Does admission to the UK benchmark index lead to a share price boost?  Continue reading

Yesterday

Turning on the taps

Infrastructure spending is rising up the agenda  Continue reading

The approval of one drug from a US company has sent the share price of many other contenders soaring, including London-listed Summit Therapeutics  Continue reading

Read on to find out the favourite stock-analysis metrics of star small-cap fund manager Harry Nimmo and how he uses them.  Continue reading

Monday,26 September 2016

Tuesday,20 September 2016

Taking Stock: One out, one back

Why being first through the door isn't always the advantage it's made out to be  Continue reading

Chart: Apple ripens on Samsung's sorrows

A global recall of the combustible Galaxy Note 7 is splendid news for iPhone sales  Continue reading

Monday,19 September 2016

Chart: should the gold price be higher?

A bar of gold costs 24 per cent more than it did at the beginning of the year, but the yellow metal's price is still way off its 2011 record highs.  Continue reading

Wednesday,14 September 2016

Are US hard hats supporting global indices?

Many believe global indices are overdue for a major correction, but we shouldn't disregard the blue-collar dynamic from across the pond  Continue reading

Monday,12 September 2016

Back by popular demand... companies with big pension deficits.  Continue reading

Most read posts this week

    Register today and get...

    Register today and get...
    Please note terms & conditions apply